Indoco Remedies trades jubilantly on receiving EIR for plant located at Goa

22 Jul 2014 Evaluate

Indoco Remedies is currently trading at Rs. 188.00, up by 23.45 points or 14.25% from its previous closing of Rs. 164.55 on the BSE.

The scrip opened at Rs. 179.00 and has touched a high and low of Rs. 197.00 and Rs. 178.00 respectively. So far 131021 shares were traded on the counter.

The BSE group 'B ' stock of face value Rs. 2 has touched a 52 week high of Rs. 197.00 on 22-Jul-2014 and a 52 week low of Rs. 55.05 on 31-Jul-2013.

Last one week high and low of the scrip stood at Rs. 197.00 and Rs. 155.60 respectively. The current market cap of the company is Rs. 1516.33 crore.

The promoters holding in the company stood at 59.20% while Institutions and Non-Institutions held 18.45% and 22.35% respectively.

Indoco Remedies has received Establishment Inspection Report (EIR) from USFDA approving the company’s sterile manufacturing facility (Plant II) and solid dosage manufacturing facility (Plant III) located in Verna, Goa. Last year in August, the USFDA had carried out inspection in the said plant.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.

 

Indoco Remedies Share Price

206.95 -1.10 (-0.53%)
21-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.55
Dr. Reddys Lab 1155.50
Cipla 1369.55
Zydus Lifesciences 876.10
Lupin 2139.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×